Internal Reference Number: FOI_6548
Date Request Received: 08/04/2022 00:00:00
Date Request Replied To: 25/04/2022 00:00:00
This response was sent via: By Email
Request Summary: Patient treatment with Nivolumab
Request Category: Companies
| Question Number 1: In the last 3 months, how many patients have been initiated* on the following agents for treatment for melanoma? 鈥� Nivolumab (monotherapy) 鈥� Nivolumab AND Ipilimumab (combination) *Patients are considered initiated if they have not been treated in the previous 6 months with any of the drugs that are part of the named regimen. | |
| Answer To Question 1: The trust does not treat melanoma, so zero patients. | |
| Question Number 2: In the last 3 months, how many patients have been initiated* on the following agents for treatment for Renal Cell Carcinoma? 鈥� Nivolumab (monotherapy) 鈥� Nivolumab + Ipilimumab 鈥� Nivolumab + Cabozantinib 鈥� Avelumab + Axitinib *Patients are considered initiated if they have not been treated in the previous 6 months with any of the drugs that are part of the named regimen. | |
| Answer To Question 2: The trust does not treat renal cell cancer so zero patients | |
| Question Number 3: In the past 3 months, how many patients have been initiated* on the following agents for treatment for Advanced/Metastatic Oesophageal Cancer: 鈥� Nivolumab (monotherapy) 鈥� Pembrolizumab in combination with Platinum (Cisplatin or Oxaliplatin) and Fluoropyrimidene (5-Fluorouracil or Capecitabine) *Patients are considered initiated if they have not been treated in the previous 6 months with any of the drugs that are part of the named regimen. | |
| Answer To Question 3: Zero patients have been initiated with these treatments for Advanced/Metastatic Oesophageal Cancer | |
| To return to the list of all the FOI requests please click here |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of 看片软件 Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
